The evidence that high‐risk HPV infections cause cervical cancers has led to two new
approaches for cervical cancer control: vaccination to prevent HPV infections, and HPV …

Cervical cancer remains a major cause of morbidity and mortality for women worldwide.
Although the introduction of comprehensive screening programs has reduced the disease …

Clin Microbiol Infect 2012; 18 (Suppl. 5): 64–69 Abstract Two prophylactic human
papillomavirus (HPV) vaccines have been recently approved: one quadrivalent and the …

Cervical cancer is a global health crisis that disproportionately affects developing nations
and underserved populations. Two vaccines targeting HPV-16 and 18, which account for …

Pap screening combined with loop electrosurgical excision procedures (LEEP) is almost
100% effective in preventing cervical cancer mortality yet many countries with these …

Human papillomaviruses (HPVs) are aetiologically linked to the development of various
benign and malignant lesions of the skin and mucosa [1–4]. The current theme issue …

The finding that cervical cancer only occurs in women infected with specific," high-risk" types
of the human papillomavirus (HPV) has led to the development of novel, non-cytology-based …

Cervical cancer is a leading cause of cancer-related deaths worldwide. The causal role of
human papillomavirus (HPV) infection in the pathogenesis of cervical cancer has prompted …

Opinion statement Nearly 500,000 new cases of cervical cancer and 274,000 cervical
cancer deaths are occurring worldwide each year. Approximately 80% of the 500,000 new …

The finding that cervical cancer only occurs in women infected with specific,“high-risk” types
of the human papillomavirus (HPV) has led to the development of novel, non-cytology-based …